文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.

作者信息

Arts J, Caenepeel P, Verbeke K, Tack J

机构信息

Department of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

出版信息

Gut. 2005 Apr;54(4):455-60. doi: 10.1136/gut.2003.035279.


DOI:10.1136/gut.2003.035279
PMID:15753526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1774442/
Abstract

BACKGROUND AND AIMS: Although delayed gastric emptying is considered a major pathophysiological mechanism in functional dyspepsia, the efficacy of prokinetic drugs has not been established. Recent studies using macrolide prokinetics were negative but receptor desensitisation may have played a role. The aim of the present study was to evaluate the influence on meal induced symptoms of acutely administered erythromycin in patients with gastroparesis. METHODS: In 20 patients with functional dyspepsia, gastric emptying was studied twice using the (14)C octanoic acid and (13)C glycin breath test to establish the reproducibility of the test. Breath samples were taken before the meal and at 15 minute intervals for a period of 240 minutes postprandially. At each breath sampling, the patient was asked to grade the intensity (0-3) of six dyspeptic symptoms. Twenty four patients (three men, mean age 43.5 (3) years) with dyspeptic symptoms and delayed gastric emptying were studied twice after pretreatment with saline or erythromycin intravenously. RESULTS: Meal related symptom severity scores were reproducible. Treatment with erythromycin significantly enhanced solid and liquid gastric emptying (t(1/2) 146 (27) v 72 (7) minutes, respectively (p<0.01), and 87 (6) v 63 (5) minutes (p<0.001)). Only the severity of bloating was significantly improved by erythromycin (23 (3.9) v 14.5 (2.7); p<0.01); all other symptoms and the cumulative meal related symptom score were not altered by erythromycin. CONCLUSIONS: In a setting where desensitisation played no role, erythromycin enhanced gastric emptying was not associated with a beneficial effect on meal related symptom severity.

摘要

相似文献

[1]
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.

Gut. 2005-4

[2]
Influence of delaying gastric emptying on meal-related symptoms in healthy subjects.

Aliment Pharmacol Ther. 2006-10-1

[3]
Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.

Aliment Pharmacol Ther. 2005-11-1

[4]
In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.

Gastroenterology. 2013-5-20

[5]
Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.

Clin Gastroenterol Hepatol. 2012-7-17

[6]
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.

Gut. 2001-9

[7]
Relationship between symptoms and ingestion of a meal in functional dyspepsia.

Gut. 2008-11

[8]
Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.

Digestion. 2012-7-27

[9]
Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers.

Am J Gastroenterol. 2001-7

[10]
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.

Aliment Pharmacol Ther. 2000-5

引用本文的文献

[1]
Diagnostic Criteria and Symptom Profiles in Adult Idiopathic Gastroparesis: A Systematic Review.

J Neurogastroenterol Motil. 2025-7-30

[2]
Pharmacological Treatment of Functional Dyspepsia: An Old Story Revisited or a New Story to Be Told? A Clinical Review.

GE Port J Gastroenterol. 2022-11-4

[3]
Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.

Nat Rev Rheumatol. 2023-3

[4]
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence.

United European Gastroenterol J. 2023-3

[5]
Management of scleroderma gastrointestinal disease: Lights and shadows.

J Scleroderma Relat Disord. 2022-6

[6]
Postprandial symptoms in patients with symptoms of gastroparesis: roles of gastric emptying and accommodation.

Am J Physiol Gastrointest Liver Physiol. 2022-7-1

[7]
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

United European Gastroenterol J. 2021-4

[8]
The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review.

Front Psychiatry. 2020-3-18

[9]
Clinical Practice Guidelines for Functional Dyspepsia in Korea.

J Neurogastroenterol Motil. 2020-1-30

[10]
Gastrointestinal Involvement in Systemic Sclerosis: An Update.

J Clin Rheumatol. 2018-9

本文引用的文献

[1]
Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways.

Am J Gastroenterol. 2006-4

[2]
Influence of tegaserod on proximal gastric tone and on the perception of gastric distension.

Aliment Pharmacol Ther. 2003-11-15

[3]
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia.

Am J Gastroenterol. 2003-4

[4]
Causes and treatment of functional dyspepsia.

Curr Gastroenterol Rep. 2001-12

[5]
Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.

Gastroenterology. 2001-9

[6]
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.

Gut. 2001-9

[7]
What comes after macrolides and other motilin stimulants?

Gut. 2001-9

[8]
Perception of changes in wall tension of the proximal stomach in humans.

Gut. 2001-8

[9]
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?

Am J Gastroenterol. 2001-5

[10]
Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.

Am J Gastroenterol. 2001-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索